4//SEC Filing
Machielse Bernardus N M 4
Accession 0001179110-13-006932
CIK 0001477598other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 9:00 PM ET
Size
6.9 KB
Accession
0001179110-13-006932
Insider Transaction Report
Form 4
Machielse Bernardus N M
Executive VP and COO
Transactions
- Conversion
Common Stock
2013-04-16+25,601→ 25,601 total - Conversion
Series B Convertible Preferred Stock
2013-04-16−35,722→ 0 total→ Common Stock (25,601 underlying)
Footnotes (2)
- [F1]Represents the total number of shares received upon conversion of shares of the Issuer's Series B Convertible Preferred Stock (the "Series B Shares").
- [F2]Effective upon the closing of the Issuer's initial public offering of its Common Stock, each Series B Share automatically converted at a ratio of 1.3953-to-1 into the number of shares of Common Stock shown in column 7. The Series B Shares had no expiration date.
Documents
Issuer
Omthera Pharmaceuticals, Inc.
CIK 0001477598
Entity typeother
Related Parties
1- filerCIK 0001315038
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 9:00 PM ET
- Size
- 6.9 KB